Literature DB >> 25637622

The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival.

Amanda Graham1, Tommaso Falcone2, Warren B Nothnick3.   

Abstract

STUDY QUESTION: What is the role of microRNA-451 (miR-451) in human endometriotic tissue? SUMMARY ANSWER: miR451 expression was elevated in endometriotic lesion tissue. MiR451 modulated the expression of macrophage migration inhibitory factor and limited cell survival. WHAT IS KNOWN ALREADY: microRNAs are post-transcriptional regulators of gene expression which have been reported to be mis-expressed in endometriotic tissue. The exact pattern of expression and role of miR451 in endometriosis is currently unknown. STUDY DESIGN, SIZE, DURATION: Thirty women with endometriosis are included in the study. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Matched eutopic (N = 30) and endometriotic lesion tissue (N = 43) were collected. miR-451, macrophage migration inhibitory factor (MIF), cyclin E1 (CCNE) and phosphatase and tensin homolog (PTEN) mRNA expression were examined by quantitative real-time (qRT)-PCR while MIF protein expression was evaluated by western blot analysis. miR-451 regulation of MIF in vitro translation was confirmed by 3'untranslated region (UTR) reporter assays and western blot analysis. The effect of miR-451 on cell survival was assessed using a human endometrial epithelial cell line (HES). MAIN RESULTS AND THE ROLE OF CHANCE: Compared with eutopic endometrium, both MIF mRNA and protein were significantly (P < 0.05) decreased in endometriotic lesions and this was associated with a significant (P < 0.05) increase in miR-451 expression. Transfection of HES cells with luciferase reporter constructs for MIF revealed that miR-451 specifically bound to the 3'UTR to regulate expression. Further, forced expression of miR-451 induced a significant (P < 0.05) down-regulation of both MIF mRNA and protein in HES cells which was associated with a significant (P < 0.05) reduction in cell survival. Inhibition of MIF using a specific antagonist verified that reduction of MIF contributes to HES cell survival. LIMITATIONS, REASONS FOR CAUTION: miR-451 and MIF expression were only examined in tissue from women with endometriosis. WIDER IMPLICATIONS OF THE
FINDINGS: Our data support the hypothesis that miR-451 is elevated in endometriotic tissue and, through regulating MIF expression, may function to limit endometriotic lesion cell survival. STUDY FUNDING/COMPETING INTERESTS: This study was funded by the National Institutes of Health/NICHD by grant NIH HD069043 to W.B.N. The authors have no competing interests.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  endometriosis; macrophage migration inhibitory factor; miRNA

Mesh:

Substances:

Year:  2015        PMID: 25637622      PMCID: PMC4325675          DOI: 10.1093/humrep/dev005

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  48 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

2.  The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression.

Authors:  Qun Pan; Xiaoping Luo; Tannaz Toloubeydokhti; Nasser Chegini
Journal:  Mol Hum Reprod       Date:  2007-08-31       Impact factor: 4.025

3.  Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease.

Authors:  Warren B Nothnick; Arlene Colvin; Kai Fan Cheng; Yousef Al-Abed
Journal:  J Endometr       Date:  2011-09-30

4.  Functional microRNA involved in endometriosis.

Authors:  Shannon M Hawkins; Chad J Creighton; Derek Y Han; Azam Zariff; Matthew L Anderson; Preethi H Gunaratne; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-03-24

Review 5.  The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.

Authors:  Yaw Asare; Martin Schmitt; Jürgen Bernhagen
Journal:  Thromb Haemost       Date:  2013-01-17       Impact factor: 5.249

6.  Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis.

Authors:  Nicoletta Filigheddu; Ilaria Gregnanin; Paolo E Porporato; Daniela Surico; Beatrice Perego; Licia Galli; Claudia Patrignani; Andrea Graziani; Nicola Surico
Journal:  J Biomed Biotechnol       Date:  2010-03-10

7.  MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration.

Authors:  Guixiang Lv; Zheng Hu; Yi Tie; Jingli Du; Hanjiang Fu; Xu Gao; Xiaofei Zheng
Journal:  Oncol Rep       Date:  2014-06-27       Impact factor: 3.906

8.  Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology.

Authors:  D T Liu; A Hitchcock
Journal:  Br J Obstet Gynaecol       Date:  1986-08

9.  Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis.

Authors:  Rouslan Kats; Tina Collette; Christine N Metz; Ali Akoum
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

Review 10.  PTEN: a new guardian of the genome.

Authors:  Y Yin; W H Shen
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

View more
  24 in total

Review 1.  Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise.

Authors:  Warren B Nothnick; Ayman Al-Hendy; John R Lue
Journal:  J Minim Invasive Gynecol       Date:  2015-03-07       Impact factor: 4.137

Review 2.  MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis.

Authors:  Warren B Nothnick
Journal:  Semin Reprod Med       Date:  2017-02-17       Impact factor: 1.303

3.  Endometrial Stromal and Epithelial Cells Exhibit Unique Aberrant Molecular Defects in Patients With Endometriosis.

Authors:  Philip C Logan; Pamela Yango; Nam D Tran
Journal:  Reprod Sci       Date:  2017-05-11       Impact factor: 3.060

4.  Altered expression of microRNA-451 in eutopic endometrium of baboons (Papio anubis) with endometriosis.

Authors:  N R Joshi; R W Su; G V R Chandramouli; S K Khoo; J W Jeong; S L Young; B A Lessey; A T Fazleabas
Journal:  Hum Reprod       Date:  2015-09-14       Impact factor: 6.918

5.  miR-200 Regulates Endometrial Development During Early Pregnancy.

Authors:  Patricia T Jimenez; Monica A Mainigi; R Ann Word; W Lee Kraus; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2016-08-17

6.  Swimming prevents nonalcoholic fatty liver disease by reducing migration inhibitory factor through Akt suppression and autophagy activation.

Authors:  Haiying Tang; Xiaoyan Tan; Lei Zhu; Kairong Qin; Huan Gao; Hao Bai
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 7.  MicroRNAs in endometriosis: biological function and emerging biomarker candidates†.

Authors:  Sarah Bjorkman; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-05-01       Impact factor: 4.285

8.  MiR-202 promotes endometriosis by regulating SOX6 expression.

Authors:  Dongli Zhang; Yanyun Li; Jun Tian; Hongxia Zhang; Shelian Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  60S acidic ribosomal protein P1 (RPLP1) is elevated in human endometriotic tissue and in a murine model of endometriosis and is essential for endometriotic epithelial cell survival in vitro.

Authors:  Zahraa Alali; Amanda Graham; Kimberly Swan; Rebecca Flyckt; Tommaso Falcone; Wei Cui; Xiaofang Yang; Julie Christianson; Warren B Nothnick
Journal:  Mol Hum Reprod       Date:  2020-01-01       Impact factor: 4.025

10.  Future Directions in Endometriosis Research and Therapeutics.

Authors:  Warren B Nothnick; Courtney Marsh; Zahraa Alali
Journal:  Curr Womens Health Rev       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.